Farther Finance Advisors’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $510K | Buy |
7,303
+1,220
| +20% | +$85.3K | 0.01% | 895 |
|
|
2025
Q1 | $442K | Buy |
6,083
+706
| +13% | +$51.3K | 0.01% | 837 |
|
|
2024
Q4 | $352K | Sell |
5,377
-24
| -0.4% | -$1.57K | 0.01% | 736 |
|
|
2024
Q3 | $421K | Sell |
5,401
-208
| -4% | -$16.2K | 0.02% | 667 |
|
|
2024
Q2 | $437K | Buy |
5,609
+1,741
| +45% | +$136K | 0.02% | 523 |
|
|
2024
Q1 | $260K | Sell |
3,868
-73
| -2% | -$4.91K | 0.02% | 597 |
|
|
2023
Q4 | $265K | Buy |
3,941
+1,877
| +91% | +$126K | 0.02% | 483 |
|
|
2023
Q3 | $140K | Buy |
2,064
+404
| +24% | +$27.4K | 0.02% | 459 |
|
|
2023
Q2 | $119K | Sell |
1,660
-170
| -9% | -$12.2K | 0.03% | 410 |
|
|
2023
Q1 | $127K | Buy |
1,830
+302
| +20% | +$21K | 0.04% | 347 |
|
|
2022
Q4 | $104K | Buy |
+1,528
| New | +$104K | 0.04% | 322 |
|